AAAAAA

   
Results: 1-12 |
Results: 12
In vitro effects of nicotine on mitochondrial respiration and superoxide anion generation
Authors: Cormier, A Morin, C Zini, R Tillement, JP Lagrue, G
Citation: A. Cormier et al., In vitro effects of nicotine on mitochondrial respiration and superoxide anion generation, BRAIN RES, 900(1), 2001, pp. 72-79
Prevalence of cannabis and tobacco use in patients attending a Methadone Center. Evaluation by urinary biomarkers
Authors: Asnafi-Farhang, S Hatchuel, P Bourhis, F Divine, C Lagrue, G
Citation: S. Asnafi-farhang et al., Prevalence of cannabis and tobacco use in patients attending a Methadone Center. Evaluation by urinary biomarkers, ANN MED IN, 152, 2001, pp. S37-S42
Can vitamin C help stop smoking?
Authors: Lagrue, G Mautrait, C Cormier, S
Citation: G. Lagrue et al., Can vitamin C help stop smoking?, PRESSE MED, 29(19), 2000, pp. 1045-1046
Relationships between sensation seeking and emotional symptomatology during smoking cessation with nicotine patch therapy
Authors: Carton, S Le Houezec, J Lagrue, G Jouvent, R
Citation: S. Carton et al., Relationships between sensation seeking and emotional symptomatology during smoking cessation with nicotine patch therapy, ADDICT BEHA, 25(5), 2000, pp. 653-662
Guidelines for medical treatment of type 2 diabetes: condensed text
Authors: Halimi, S Rostoker, G Altman, JJ Attali, C Beaune, J Belorgey-Bismut, C Bouldouyre-Magnier, AM Cordonnier, D Denis, C Duranteau, L Grimaldi, A Guillausseau, PJ Koenig, F Lagrue, G Monnier, L Orgiazzi, J Raucoules-Aime, M Saltiel, H Simon, D Varroud-Vial, M
Citation: S. Halimi et al., Guidelines for medical treatment of type 2 diabetes: condensed text, J FR OPHTAL, 23(3), 2000, pp. 302-306
Vascular hyperpermeability in nephrotic edema
Authors: Rostoker, G Behar, A Lagrue, G
Citation: G. Rostoker et al., Vascular hyperpermeability in nephrotic edema, NEPHRON, 85(3), 2000, pp. 194-200
Guideliness for drug treatment of type 2 diabetes mellitus
Authors: Halimi, S Rostoker, G Altman, JJ Attali, C Beaune, J Belorgey-Bismut, C Bouldouyre-Magnier, AM Cordonnier, D Denis, C Duranteau, L Grimaldi, A Guillausseau, PJ Koenig, F Lagrue, G Monnier, L Orgiazzi, F Raucoules-Aime, M Saltiel, H Simon, D Varroud-Vial, M
Citation: S. Halimi et al., Guideliness for drug treatment of type 2 diabetes mellitus, ANN ENDOCR, 61(2), 2000, pp. 168-173
The treatment of type 2 diabetes. Report of the expert commitee of the AFSSAPS
Authors: Halimi, S Rostoker, G Altman, JJ Attali, C Beaune, J Belorgey-Bismut, C Bouldouyre-Magnier, AM Cordonnier, D Denis, C Duranteau, L Grimaldi, A Guillausseau, PJ Koenig, F Lagrue, G Monnier, L Orgiazzi, J Raucoules-Aime, M Saltiel, H Simon, D Varroud-Vial, M
Citation: S. Halimi et al., The treatment of type 2 diabetes. Report of the expert commitee of the AFSSAPS, DIABETE MET, 25(6), 1999, pp. 533-550
Unexpected consequence of using "joints"
Authors: Lagrue, G Cormier, S Divine, C
Citation: G. Lagrue et al., Unexpected consequence of using "joints", PRESSE MED, 28(21), 1999, pp. 1112-1113
Therapeutic nicotinic replacement and list of approved drugs.
Authors: Lagrue, G
Citation: G. Lagrue, Therapeutic nicotinic replacement and list of approved drugs., J MAL VASC, 24(5), 1999, pp. 384-385
Help in stopping smoking: it's time for action.
Authors: Lagrue, G Cormier, S Mautrait, C
Citation: G. Lagrue et al., Help in stopping smoking: it's time for action., J MAL VASC, 24(4), 1999, pp. 263-265
Nicotine replacement therapy and smoking cessation: what choice for its status?
Authors: Lagrue, G
Citation: G. Lagrue, Nicotine replacement therapy and smoking cessation: what choice for its status?, B ACA N MED, 183(6), 1999, pp. 1175-1187
Risultati: 1-12 |